基于ZIF-8的纳米载体农药输送系统对向释放和杀虫剂活性的大小影响
Zhou Gao1, Jinfang Tan1, Yuqing Sun1
1School of Agriculture and Biotechnology, Sun Yat-sen University, Shenzhen, P. R. China.
Pest management science
|October 28, 2024
概括
这项研究开发了dinotefuran@zeolitic imidazolate framework-8@polydopamine@zein (DNF@ZIF-8@PDA@zein) 纳米颗粒用于向的害虫防治. 较小的纳米颗粒显示了增强的pH值和酶响应释放,改善光稳定性,并增加了可持续农业的杀虫活性.
科学领域:
- 材料科学 材料科学 材料科学
- 纳米技术纳米技术
- 农业化学 农业化学
背景情况:
- 传统的化学杀虫剂由于流失和低目标交付导致环境污染.
- 开发可控释放配方对于有效和环保的害虫管理至关重要.
研究的目的:
- 为了合成和表征dinotefuran@zeolitic imidazolate框架-8@polydopamine@zein (DNF@ZIF-8@PDA@zein) 纳米粒子.
- 为了评估dinotefuran (DNF) 的pH值和酶反应释放.
- 评估纳米粒子大小对DNF释放,光稳定性和杀虫活性的影响.
主要方法:
- 合成不同尺寸的DNF@ZIF-8@PDA@zein纳米粒子.
- 在不同pH值 (5.0和8.0) 的体外释放研究中,有或没有蛋白酶.
- 与纯 DNF.相比,光稳定性的评估.
- 对杀虫剂活性和抑制排毒酶的评估.
主要成果:
- 合成的纳米粒子直径为249.73nm,142.94nm和75.16nm.
- 在pH值5.0和蛋白酶存在下,显著增加DNF释放.
- 释放效率和杀虫活性随着纳米粒子大小的减少而增加.
- 增强的抗光解能力 (纯DNF的3.2倍) 和更大的排毒酶的抑制.
结论:
- DNF@ZIF-8@PDA@zein纳米粒子表现出pH和酶双反应释放,更小的尺寸提高了疗效.
- 开发的纳米粒子提供了有效的长期害虫防治,并显示了可持续农业应用的潜力.
相关概念视频
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.


